We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

AstraZeneca Faces New Class-Action Suit Over Prilosec Patent Expiration

Law360 (January 27, 2005, 12:00 AM EST) -- U.K.-Swedish drug maker AstraZeneca is facing yet another class-action lawsuit over the way the company allegedly weaned patients off the ulcer drug Prilosec after its patent expired and on to its...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.